b-rayZ AG
PrivateLast Round
Series A
Extension
Jun 30, 2025
Total Funding Raised
$4.29M
Company Overview
b-rayZ AG operates in Healthcare & Life Sciences and is based in Schlieren. Its latest recorded funding round was a Series A Extension round in June 2025.
b-rayZ AG is a health technology company that develops an AI-powered platform for breast cancer diagnostics and imaging workflow optimization.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Workflow Automation, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
b-rayZ AG Comparables
Compare b-rayZ AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Densitas Inc. | 89% | |
| ScreenPoint Medical | 86% | |
| Therapixel | 86% |
For institutional investors. Book with your work email.
b-rayZ AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 30, 2025 | ||||
| Series A | Jul 7, 2022 | ||||
| Grant | May 6, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
b-rayZ AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Convergence Partners AG | Series A |
| Gebert Rüf Stiftung | Grant |
| LifeCare Partners | Series A |
| Eckenstein-Geigy-Stiftung | Series A |
| Protagon AG | Series A |
| Venture Kick | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 23, 2026
Grew 16% QoQ, from 19 to 22 employees.
- Jan 6, 2026
Monthly visitors increased 51% MoM.
For institutional investors. Book with your work email.
b-rayZ AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about b-rayZ AG's valuation, stock price, and market status.
Is b-rayZ AG a public or private company?
b-rayZ AG is a private company.
What is the current stock price of b-rayZ AG?
b-rayZ AG is a private company, so its shares have no public market price. Caplight tracks b-rayZ AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is b-rayZ AG worth (valuation)?
Valuation information for b-rayZ AG is not publicly available.
Can I buy b-rayZ AG stock?
b-rayZ AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was b-rayZ AG's last funding round?
b-rayZ AG's most recent funding round was Series A Extension on June 30, 2025.
Who are the main investors in b-rayZ AG?
Key investors in b-rayZ AG include Convergence Partners AG, LifeCare Partners, Protagon AG.
Will b-rayZ AG IPO soon?
No public IPO plans have been announced for b-rayZ AG.
How can I track b-rayZ AG secondary market activity?
Caplight tracks bids, offers, and trades in b-rayZ AG's shares on secondary markets.